R heumatoid arthritis (RA)
3 is a chronic inflammatory disease that mainly affects the synovial membranes, cartilage, and bone of diarthrodial joints, but also has systemic effects, such as the presence of autoantibodies (1) . Although its cause is largely unknown, an autoimmune reaction has been suggested to precede the clinically detectable onset of inflammatory arthritis. It is probable that the autoimmune reaction is due to escape of autoreactive T cells from self-tolerance mechanisms and that these T cells subsequently help cognate B cells to secrete autoantibodies. Such autoantibodies play a central role in joint destruction by triggering FcR-mediated and complement-mediated inflammatory cascades. Osteoclasts are activated late in the inflammatory response and participate aggressively in bone destruction. These pathogenic processes are relatively well mimicked in the K/BxN mouse model of RA.
In K/BxN TCR-transgenic mice, the spontaneous development of severe arthritis, with 100% penetrance, requires the transgenic T cells to recognize a self-peptide from glucose-6-phosphate isomerase (GPI) in the context of MHC I-A g7 (2) . B cells secreting GPIspecific Abs are crucial for maintaining the disease, as evidenced by the fact that the autoantibodies alone can transfer the disease to naive mice (3) . Previously, we found that autoreactive CD4 ϩ T cells proliferated homeostatically to compensate for the lymphopenia and suggested that this process might be the cause of the arthritis (4) . It was unclear, however, how the homeostatically expanding memory-like CD4 ϩ
CD25
Ϫ T cells drove the arthritis development, which is mainly due to autoantibody-mediated innate effector functions. Recently, a novel cytokine, IL-21, has been found to play a central role in B cell differentiation and function, raising the possibility that it may link these two arthritis-related events.
IL-21 is a type I cytokine that shares sequence homology with the other members of the family, such as IL-2, -4, and -15 (5) . In mice and humans, it is produced by activated CD4 ϩ T subsets including Th17, follicular Th (T FH ), memory CD4 ϩ T, and NKT cells (6 -9) . It signals through a unique receptor, IL-21R, which is similar to IL-2/IL-15R␤ and IL-4R␣ chains, and the common ␥-chain (10) . IL-21R is widely expressed in lymphoid-lineage cells, regulating the proliferation and differentiation of these cells. In particular, IL-21 stimulates the proliferation of both T and B cells, enhances the cytotoxic activity of CD8 ϩ T cells, and induces the terminal differentiation of NK cells (11) (12) (13) . IL-21 signals are crucial for the differentiation of naive B cells to IgG1 or IgG3 isotype-switched memory B and plasma cells (14) .
Several pieces of evidence suggest that the IL-21/IL-21R system is involved in the pathogenesis of various autoimmune diseases. In vivo administration of IL-21 before inducing experimental autoimmune encephalomyelitis exacerbated the resulting disease by boosting IFN-␥ secretion by NK cells (15) . Moreover, blocking IL-21 signals effectively suppressed disease progression by affecting adaptive immune responses in the murine MRL-Fas lpr and collagen-induced arthritis models (16, 17) . Intriguingly, the results obtained with the collagen-induced arthritis model indicated that IL-21 decreased IFN-␥ production, in addition to modulating B cell function. Investigations using IL-21R-deficient NOD mice showed that IL-21 is crucial for the development of type 1 diabetes via mechanisms independent of homeostatic proliferation of CD4 ϩ T cells (18) , which was previously suggested to result from IL-21 activity (19) . These investigations all lead to the conclusion that IL-21 signaling plays pathogenic roles in the development of some autoimmune diseases, but the mechanisms suggested to underlie IL-21 action are diverse and even conflict with each other. Moreover, there have been reports that IL-21 signaling is actually dispensable for, and even suppresses, the development of experimental autoimmune encephalomyelitis (20, 21) . Thus, the role of IL-21 in autoimmune diseases remains unclear.
We undertook the present study to investigate the mechanism by which homeostatically proliferating CD4 ϩ T cells precipitate autoantibody-dependent arthritis in K/BxN mice. We demonstrate that IL-21 is produced by the homeostatically proliferating CD4 ϩ CD25 Ϫ T cells via an autocrine positive feedback loop and that IL-21 signaling plays diverse roles in the development of the autoimmune arthritis.
Materials and Methods

Mice
A cross between KRN TCR-transgenic mice on a C57BL/6 background (K/B) and NOD mice generated arthritic transgenic progeny (K/BxN) and nontransgenic littermates (BxN) (2) . IL-21R ϩ/Ϫ K/B mice were produced by crossing IL-21R Ϫ/Ϫ C57BL/6 mice (14) with KRN TCR-transgenic mice. IL-21R Ϫ/Ϫ mice on a C57BL/6 background were backcrossed to NOD for more than eight generations and crossed to the IL-21R ϩ/Ϫ K/B mice to generate IL-21R Ϫ/Ϫ K/BxN mice. All mice were maintained in a specific pathogen-free barrier facility at Hanyang University and used 5-10 wk after birth for all experiments, except where indicated. The studies were approved by the Animal Care and Use Committee of Hanyang University.
Abs and flow cytometry
Single-cell suspensions of spleen and lymph node (LN) cells were surface or intracellularly stained as previously described (8) . The following mAbs were purchased from BD Biosciences: anti-B220 (RA3-6B2), anti-CD4 (RM4-5), anti-CXCR5 (2G8), anti-CD138 (281-2), anti-IgG1 (A85-1), antiIgG2a/2b (R2-40), anti-IL-17 (TC11-18H10.1), and anti-Ki-67 (B56). The following mAbs were obtained from eBioscience: anti-B7.1 (16-10A1), anti-CD25 (7D4), anti-Foxp3 (FJK-16s), anti-IFN-␥ (XMG1.2), and anti-IL-4 (BVD6-24G2). The mAbs were used as FITC, PE, PerCP, or allophycocyanin conjugates.
Clinical and histopathologic evaluation of arthritis
Arthritic symptoms were inspected in a blinded manner and disease severity was evaluated using a previously described scoring system (4). In this system, the maximal score per mouse is 16 and scores are expressed as the mean arthritic index on a given day. The thickness of both hind ankles was measured axially across the malleoli using a caliper (Mitutoyo). Hind paws were removed postmortem, fixed, and decalcified in 5.5% EDTA in phosphate-buffered formalin. They were then embedded in paraffin, sectioned, and stained with H&E. Arthritis-related manifestations in the ankle and foot were scored from 0 to 4, as described previously (4) .
Induction of arthritis by transfer of K/BxN serum
Serum was collected from 8-to 12-wk-old arthritic K/BxN mice and injected i.p. at 150 l/mouse twice at 24-h intervals into wild-type (WT) and
IL-21R
Ϫ/Ϫ C57BL/6 mice. Arthritic severity was determined daily for 9 days.
Cell and reagent delivery to mice
To inhibit homeostatic proliferation, 3-wk-old K/BxN mice in the preclinical phase of disease were injected i.v. with 2 ϫ 10 7 CD4 ϩ cells from BxN mice. Two weeks later, arthritis symptoms were evaluated and immunohistochemical examination was conducted as described above. To block IL-21 signaling, 18-day-old K/BxN mice were injected i.p. with 20 g/ mouse/day rIL-21R-Fc (R&D Systems) or human IgG1 (Sigma-Aldrich) on 6 consecutive days. Joint swelling of all paws was inspected blind and expressed as the arthritic index, and the thickness of the ankles of the hind paws was measured. Hind paw joints from mice 15 days after the first injection were examined by histopathologic methods, and the histopathologic index was determined as described previously (4) .
Immunohistochemistry
Hind paw tissues were fixed, embedded in paraffin, and sectioned at 7 m in thickness. Endogenous peroxidase was inactivated by treatment with 0.4% H 2 O 2 in absolute methanol. After blocking nonspecific binding with 10% normal rabbit serum in PBS, the sections were incubated with rabbit anti-mouse IL-21 (eBioscience), goat anti-mouse IL-21R (R&D Systems), or goat anti-receptor of activator of NF-B ligand (RANKL; Santa Cruz Biotechnology) Ab at appropriate dilutions. The sections were incubated with secondary Ab and exposed to avidin-biotin-peroxidase complexes and 3,3Ј-diaminobenzidine (Vector Laboratories). The sections were counterstained with 1% methyl green solution.
Analysis of IL-21/IL-21R expression by RT-PCR
RBC-depleted unfractionated or fractionated splenocytes were subjected to RT-PCR. CD4
ϩ CD25 ϩ and CD4 ϩ CD25 Ϫ cells from the spleens of BxN and K/BxN mice were sorted by FACSAriaII (BD Biosciences), and total RNA was purified using TRIzol reagent (Invitrogen). Levels of IL-21 and IL-21R mRNA were measured by semiquantitative or quantitative RT-PCR using an iCycler thermocycler (Bio-Rad). Relative amounts of IL-21 and IL-21R cDNAs were normalized to ␤ 2 -microglobulin (␤ 2 M). The primer sequences used were as follows: IL-21 forward, 5Ј-CGC CTC CTG ATT AGA CTT CG-3Ј and IL-21 reverse, 5Ј-TGT TTC TTT CCT CCC CTC CT-3Ј; IL-21R forward, 5Ј-ATG GCT ATC CAG CCA TGA AC-3Ј and IL-21R reverse, 5Ј-GGG TCC TTC ATC AGT CTC CA-3Ј; and ␤ 2 M forward, 5Ј-TGA CCAGCT TGT ATG CTA TC-3Ј and ␤ 2 M reverse, 5Ј-CAG TGT GAG CCA GGA TAT AG-3Ј.
ELISA and ELISPOT assays
Sera were collected from 7-to 9-wk-old mice and analyzed by ELISA to measure GPI-specific Ab levels, as previously described (4). GPI-specific IgG1-secreting cells in the spleen, LNs, and bone marrow (BM) were enumerated by GPI-specific ELISPOT assays as previously described, with modifications (22) . In brief, 96-well multiscreen plates (Millipore) were coated with rabbit GPI (Sigma-Aldrich) and blocked with RPMI 1640 medium containing 10% FBS. Aliquots of serial dilutions of cell suspensions from spleens, LNs, and BM were added to the GPI-coated plates and incubated overnight at 37°C in a 5% CO 2 incubator. Biotinylated anti-mouse IgG1 mAb (BD Biosciences) was added to the plates, followed by streptavidin-peroxidase (Sigma-Aldrich). After adding AEC substrate (BD Biosciences), the numbers of spots of GPI-specific IgG1 Ab-secreting cells (ASCs) were counted with a video-based automatic ELISPOT reader.
Western blot analysis of RANKL production
RBC-depleted splenocytes from WT and IL-21R
Ϫ/Ϫ BxN mice were cultured in the presence or absence of 50 ng/ml rIL-21 (R&D Systems) at 37 o C in a 5% CO 2 incubator. After culture for 48 h, the cells were harvested and subjected to Western blot analysis. In some experiments, ankle joint tissue, freed of soft tissue and bone, was digested with 400 Mandl U/ml Liberase Blendzyme II (Roche) for 1 h at 37 o C to prepare single-cell suspension of synovial cells. The cells were lysed and the lysate was fractionated by 12% SDS-PAGE and transferred to a polyvinylidene difluoride membrane (Amersham Pharmacia). The membrane was preincubated with 0.5% nonfat dried milk-containing TTBS (0.1% Tween 20 in TBS) and probed with anti-RANKL Ab (R&D Systems). After washing, the membranes were incubated with HRP-conjugated secondary Ab. The immunoreactive proteins were visualized with an ECL detection system (Santa Cruz Biotechnology). 
Statistical analyses
Results
IL-21 produced by homeostatically expanding CD4
ϩ CD25 Ϫ T cells is associated with spontaneous arthritis in K/BxN mice To address the possibility that the IL-21/IL-21R system is involved in the pathogenesis of autoimmune arthritis, we determined levels of IL-21 and IL-21R gene expression and the proportions of IL-21-and IL-21R-expressing cells in arthritic K/BxN mice. The distal joints of K/BxN mice with spontaneous full-blown arthritis contained numerous IL-21-and IL-21R-expressing cells, whereas those of their non-arthritic BxN littermates did not (Fig. 1A) . K/BxN mice that had been infused with nonpathogenic syngeneic CD4 ϩ T cells from BxN mice to inhibit the homeostatic proliferation of autoreactive T cells exhibited neither arthritic symptoms nor the emergence of IL-21-and IL-21R-expressing cells in joint tissue (Fig. 1B and data not shown) . The latter seemed to develop in the secondary lymphoid organs and migrate into the synovial ϩ/Ϫ and IL-21R Ϫ/Ϫ K/BxN mice was inspected blind. The arthritic index of all paws (left), ankle thickness of hind paws (middle), and cumulative incidence (right) are shown (n ϭ 9 -10 mice/group). B, Hind paws from 7-wk-old mice were examined by histopathologic methods. Representative photographs from each group are shown. Original magnification, ϫ100. C, WT and IL-21R Ϫ/Ϫ C57BL/6 mice were injected with K/BxN serum. Nine days after injection, joint swelling of all paws was inspected blind and the ankle thickness of hind paws was measured (n ϭ 6 mice/group). Data are means Ϯ SEM. ‫,ء‬ p Ͻ 0.05; ‫,ءء‬ p Ͻ 0.01; and ‫,ءءء‬ p Ͻ 0.001 by Student's t test.
tissue, because the expression of both IL-21 and IL-21R was substantially higher in K/BxN mouse splenocytes than in BxN splenocytes (Fig. 1C) . Among the CD4 ϩ T cells from K/BxN mice, CD25
Ϫ cells, rather than CD25 ϩ cells, were the main source of IL-21 (Fig. 1D) . The levels of IL-21R were not significantly different between CD4 ϩ CD25 ϩ and CD4 ϩ CD25 Ϫ cells, regardless of the mouse strains from which they were derived. Because most CD4
ϩ CD25 Ϫ cells from K/BxN mice are homeostatically expanding cells that retain a memory phenotype (4, 23) , these results suggest that not only is the in vivo production of IL-21 attributable to the homeostatically expanding CD4 ϩ CD25
Ϫ cells but also that the IL-21 play a role in this lymphopenic model of arthritis.
IL-21R deficiency completely blocks the spontaneous development of arthritis in K/BxN mice but does not affect the progression of serum-transferred arthritis
We assessed the role of IL-21 signaling in the development of arthritis in the K/BxN mice using IL-21R-deficient (IL-21R Ϫ/Ϫ ) K/BxN mice. Remarkably, none of the IL-21R
Ϫ/Ϫ K/BxN mice showed any symptoms of arthritis up to day 35 of birth, whereas all their IL-21R ϩ/Ϫ K/BxN littermates displayed full-blown arthritis ( Fig. 2A) . None of the parameters, including arthritic index, ankle thickness, and incidence, differed between IL-21R ϩ/ϩ and IL-21R ϩ/Ϫ K/BxN mice (data not shown), and hind paw histopathology correlated closely with clinical data in individual mice. Severe leukocyte infiltration and bone invasion were observed in all the K/BxN mice, whereas the integrity of the joint architecture of the IL-21R Ϫ/Ϫ K/BxN mice was comparable to that of normal BxN mice (Fig. 2B) . These data provide robust evidence that IL-21R-mediated signals are essential for arthritis initiation in K/BxN mice.
K/BxN serum can transfer arthritis to normal mice by virtue of the abundant autoantibodies in the serum, which trigger innate inflammatory cascades in the joints (3). To determine whether IL-21 signals affect the innate effector stage, we tested the susceptibility of WT and IL-21R Ϫ/Ϫ C57BL/6 mice to K/BxN serum-transferred arthritis. Regardless of the presence or absence of IL-21R, all mice that received K/BxN serum developed joint pathology of similar severity (Fig. 2C) . Thus, this result indicates that IL-21 is not required for arthritis development during the stage of innate effector function and suggests that it is required during adaptive autoimmune responses.
To confirm the IL-21 requirement for arthritogenicity, we repeatedly injected 18-day-old K/BxN mice with soluble rIL-21R-Fc fusion protein (20 g/mouse/day on 6 consecutive days) to block IL-21 signaling during the preclinical phase of the disease. This delayed disease onset and progression (Fig. 3A) . In the same vein, the IL-21R-Fc-treated mice exhibited more normal histology and produced less GPI-specific IgG and IgG1 Ab (Fig. 3, B-D) . Thus, these data confirm that IL-21 contributes to the induction of arthritis in K/BxN mice.
IL-21 signals form a positive feedback loop along with the homeostatically proliferating CD4 ϩ T cells and promotes the development of follicular helper T cells
We asked whether the IL-21 produced by the homeostatically expanding CD4 ϩ CD25 Ϫ T cells acts on these T cells in an autocrine manner to induce homeostatic proliferation. IL-21R Ϫ/Ϫ K/BxN mice contained significantly fewer CD4 ϩ T cells in their spleens and joint draining LNs (dLNs), a pool of axillary, inguinal, and popliteal LNs, than their IL-21R ϩ/Ϫ K/BxN littermates (Fig. 4A ). This reduction may be due to reduced homeostatic proliferation, because the fraction of CD4 ϩ T cells expressing Ki-67, which is exclusively expressed in the nuclei of proliferating cells, was significantly lower in the IL-21R Ϫ/Ϫ K/BxN mice than in the IL-21R ϩ/Ϫ K/BxN mice (Fig.  4B) . Memory-like phenotypes (CD25 Ϫ CD44 high ) are known to be a hallmark of homeostatically proliferating CD4 ϩ T cells (23), and we found that PD-1 and B7.1 were also more highly expressed on the CD4 ϩ CD25 Ϫ cells from K/BxN mice than on those from BxN controls. These bizarre phenotypic changes were significantly reduced in the dLNs but not in the spleens of IL-21R Ϫ/Ϫ K/BxN mice. These results suggest that IL-21 forms a positive feedback autocrine loop along with the homeostatic proliferation of the CD4 ϩ cells that drives the development of arthritis. CXCR5 ϩ T FH cells are specialized in helping germinal center B cells during Ab responses to T cell-dependent Ags (24, 25) , and it has recently been suggested that IL-21 generates T FH cells (26, 27) . We tested the connection between IL-21 and T FH cells in our system. As expected, there was a substantially larger fraction of CXCR5 ϩ cells among the CD4 ϩ CD25 Ϫ population in both the dLNs and spleens of arthritic K/BxN mice than in those of normal BxN mice, and this fraction was markedly reduced in the dLNs, but not the spleens, of IL-21R Ϫ/Ϫ K/BxN mice (Fig. 4D) . These findings indicate that IL-21 can expand the T FH cell population, which is restricted to LNs adjacent to inflamed tissue rather than distributed systemically, thereby indirectly contributing to longlasting humoral immunity.
The pathogenic role of IL-21 in K/BxN mice is independent of Th17 and regulatory T (Treg) cells
IL-17-producing CD4
ϩ Th (Th17) effector cells are critical for pathogenicity in models of collagen-induced arthritis and SKG arthritis (28, 29) . In addition, IL-17 overexpression aggravates K/BxN serum-transferred arthritis, implying that IL-17 may be pathogenic in K/BxN mice (30) . IL-21, along with IL-6, has emerged as a master cytokine promoting differentiation of naive CD4 ϩ T cells into Th17 cells and blocking the TGF-␤-mediated conversion of naive CD4 ϩ T cells into Foxp3 ϩ Treg cells (31) . Indeed, this idea was further supported by in vivo data showing that IL-21R knockout mice have impaired Th17 cell development (18) , although this is a matter of debate.
We determined the impact of IL-21R deficiency on the balance between Th17 and Treg cells in arthritic K/BxN mice. Arthritic IL-21R ϩ/Ϫ K/BxN mice contained a higher proportion of Th17 cells in their spleens and dLNs than BxN controls. Surprisingly, IL-21R Ϫ/Ϫ K/BxN mice, despite the absence of arthritis, contained an ϳ2-fold higher proportion of Th17 cells than their heterozygous counterparts (Fig. 5A) . However, this increase may not be due to IL-6-mediated induction of Th17 cells, because IL-6-producing cells were rare (Ͻ1% of total B and CD4 ϩ T cells) in both strains (data not shown). In contrast to Th17 cells, the proportion of CD4 ϩ Foxp3 ϩ T cells was reduced in the IL-21R Ϫ/Ϫ K/BxN mice compared with controls (Fig. 5B) . This probably reflects the inverse relationship between the development of Th17 and Treg (Fig. 5C) . Thus, it is likely that in K/BxN mice Th17 cells develop independent of IL-21 signaling or are even inhibited by it and that IL-21-elicited arthritis is not related to the roles of Th17 and Treg cells.
IL-21 signals are indispensable for autoantigen-specific IgG1 Ab production in the K/BxN model
Several cytokines, including IL-4, -6, -10, and -21, participate in B cell proliferation, differentiation, and/or isotype switching (32) . Due to functional redundancy among these cytokines, the importance of the role of IL-21 in autoantigen-specific humoral immunity remains unclear. Hence, we examined whether IL-21 signaling was critical for the activation of arthritogenic B cells.
IL-21R deficiency significantly reduced the number of B220 ϩ cells in the spleens and dLNs of K/BxN mice (Fig. 6A) . The most dramatic effect of IL-21R deficiency was on aspects of B cell differentiation: whereas most of the B220 ϩ cells populating the spleens and dLNs (Ͼ96%) of K/BxN mice were surface IgG1 ϩ memory B cells, the latter cells made up only ϳ1% of the corresponding cell populations in IL-21R Ϫ/Ϫ K/BxN mice, as was also the case in BxN mice (Fig. 6B) . IgG2 isotype-switched memory B cells made up ϳ5% of the total B220 ϩ cells and this proportion did not differ significantly between strains. As shown by ELISPOT assays, GPI-specific IgG1 ASCs were much rarer in the spleens, dLNs, and BMs of IL-21R Ϫ/Ϫ K/BxN mice than in those of their IL-21R ϩ/Ϫ K/BxN littermates (Fig. 6C) . Serum levels of GPIspecific whole IgG and IgG1 Abs were high in K/BxN mice but too low to be detectable in IL-21R Ϫ/Ϫ K/BxN mice (Fig. 6D ). These results demonstrate that IL-21 signaling is essential and nonredundant for the development of IgG1 isotype-switched memory B cells and ASCs.
IL-21-mediated induction of RANKL in T cells contributes to arthritis progression in K/BxN mice
RANKL is a member of the TNF ligand superfamily, expressed by activated T cells and osteoblasts (33, 34) . RANKL binding to RANK, a single receptor, mediates osteoclast formation and function, leading to bone resorption and bone loss. Several reports have demonstrated a role of RANKL in RA pathogenesis (35) .
We found that the hind paw joints of IL-21R ϩ/Ϫ K/BxN mice contained abundant synovial infiltrates expressing RANKL, whereas those from IL-21R Ϫ/Ϫ K/BxN mice contained few (Fig.  7A ). In the same way, RANKL was highly expressed by cells extracted from the synovial tissue of K/BxN mice, but was undetectable in the synovial tissue of IL-21R Ϫ/Ϫ K/BxN mice (Fig.  7B) . This observation might simply reflect a difference in the number of synovial infiltrates containing activated T cells and/or imply that RANKL expression is induced by IL-21. To assess the latter possibility, splenocytes from WT BxN and IL-21R Ϫ/Ϫ BxN mice were stimulated with IL-21 and the level of RANKL gene expression was determined by Western blot assays. A single treatment with IL-21 was sufficient to induce RANKL expression in the splenocytes from WT BxN mice (Fig. 7C) , whereas RANKL was not induced when cells of the IL-21R Ϫ/Ϫ BxN mice were stimulated with IL-21, confirming the IL-21 inducibility of RANKL expression. Thus, these data reveal that IL-21 is a potent inducer of RANKL gene expression and suggest a new route by which IL-21 elicits bone destruction in affected joints.
Discussion
In the present study, we found that deficiency of a single factor, IL-21R, was sufficient to completely block arthritis initiation in the K/BxN model but did not alter its susceptibility to serumtransferred arthritis. These observations point to an essential role of IL-21 signaling in the pathogenesis of arthritis, especially during adaptive autoimmune responses rather than the innate inflammatory phase. Indeed, our observations on IL- ϩ T cells in NOD mice, leading to autoimmune diabetes. In contrast, it was recently reported that, although IL-21R-deficient NOD mice did not develop type 1 diabetes, they contained T cell numbers and an IL-21 production capacity comparable to those of WT NOD mice, suggesting that there was no connection between IL-21 and the homeostatic proliferation of CD4 ϩ T cells (18) . Our results are in line with and extend the former report, since we found that the level of IL-21 correlated with the severity of arthritis, and that a positive feedback loop exists between IL-21 and homeostatic CD4 ϩ T cell proliferation. Moreover, we found that the levels of PD-1 and B7.1, which were up-regulated in the CD4 ϩ CD25 Ϫ T cells from WT K/BxN mice relative to BxN controls, were reduced in IL-21R Ϫ/Ϫ K/BxN mice. Therefore, we postulate that, in addition to its effect on proliferation, IL-21 signaling regulates the phenotypes of the homeostatically proliferating CD4 ϩ T cells, even though it is not yet clear whether these phenotypes are related to the pathogenic action of these CD4 ϩ T cells.
It has recently emerged that not only is IL-21 a critical inducer of Th17 cell development but that its pathogenic effect in experimental colitis depends on an increased ratio of Th17 cells to Treg cells (36) . In the light of that report, our results are surprising, because we found that IL-21R Ϫ/Ϫ K/BxN mice contained more Th17 cells than K/BxN mice and that, despite this, the IL-21R Ϫ/Ϫ K/BxN mice failed to develop arthritis. The pathogenic effect of IL-21 may depend on the level of IL-6, in view of the fact that IL-21 is not required for the development of Th17 cell autoimmunity in vivo in IL-6-replete conditions (20) . Therefore, we suspected that the IL-21R Ϫ/Ϫ K/BxN mice might produce more IL-6 than WT K/BxN mice, thus bypassing the need for IL-21 for Th17 cell development. However, this was not the case, because IL-6-producing cells constituted Ͻ1% of the CD4 ϩ T and B cells in both WT and IL-21R Ϫ/Ϫ K/BxN mice. Although we could not detect Th17 cell inducers in IL-21R Ϫ/Ϫ K/BxN mice, our finding that IL-21R deficiency completely inhibited the pathogenic effect of Th17 cells suggests that IL-21 affects the development of arthritis upstream of, and/or more crucially than, Th17-elicited responses.
Our results pointing out a pathogenic role for IL-21 in the K/BxN model of RA are consistent with the therapeutic effect of the IL-21 blockade in a collagen-induced arthritis model (17) . However, although the two studies agree on the pathogenic role of IL-21, the mechanisms suggested for its action differ. The findings of Young et al. (17) that IL-21 increases both IL-6 and IL-17 production, decreases IFN-␥ production, and is independent of type II collagen-specific IgG1 autoantibody production are contrary to our evidence that the pathogenic role of IL-21 is independent of IL-6/IL-17/IFN-␥ and relies mainly on IgG1 autoantibody production. This difference is not surprising, since two systems differ in terms of pathogenic processes involved and the timing of depletion of IL-21 signals. Nevertheless, it is noteworthy that both studies lead to the conclusion that IL-21 is a potential therapeutic target in human RA.
A previous report showed that IL-4 contributes to arthritis initiation by promoting GPI-specific IgG production, in particular that of IgG1 isotype autoantibodies (37) . Therefore, IL-4 and IL-21 may be functionally redundant in terms of IgG1 isotypeswitched autoantibody production in these mice. In terms of overall outcome, IL-4 deficiency had a more modest effect than IL-21R deficiency, since only 33% of IL-4 Ϫ/Ϫ K/BxN mice failed to develop arthritis (37), compared with 100% of IL-21R Ϫ/Ϫ K/BxN mice. Thus, IL-21 signals elicit arthritogenic activities more potently than IL-4 signals in the K/BxN arthritis model.
We also found that IL-21 was a potent inducer of RANKL production. This may partly account for the low numbers of RANKL-expressing cells in the synovial tissue of IL-21R-deficient K/BxN mice. How IL-21 induces RANKL expression remains unknown. Previously, IL-21-mediated signaling has been shown to activate Jak kinases and STAT transcription factors (5), and the RANKL promoter has been shown to bear an IFN-␥ activation sequence (GAS), a cis-element bound by STATs (38) . This suggests that IL-21 signals may activate the RANKL promoter through Jak-STAT pathways and this possibility is currently under investigation. Given that RANKL is important for the development and function of osteoclasts (33) (34) (35) , our data showing the IL-21 inducibility of RANKL reveal a novel mechanism by which IL-21 elicits synovial tissue damage other than by regulating adaptive immunity.
In summary, we demonstrate that IL-21 is indispensable for arthritis development in K/BxN mice where IL-21 impinges on several checkpoints of the arthritogenic cascades. Although IL-21 signals are required during the adaptive immune phase rather than the innate effector phase, IL-21-mediated arthritogenicity seems to be independent of Th17 and Treg cell function. IL-21 is produced by homeostatically proliferating CD4 ϩ CD25 Ϫ T cells and amplifies the expansion of these cells in a positive feedback autocrine manner. It promotes the development of T FH , autoantigen-specific IgG1 isotype-switched memory and plasma cells. It also accelerates the progression of arthritis by inducing RANKL expression on lymphocytes able to enter synovial infiltrates. These indirect and direct pathways may converge to trigger autoantibody-dependent synovitis. Thus, our results provide novel insight into the nature of IL-21-driven arthritogenesis and point to a target for the treatment of autoimmune arthritis.
